Green Thumb Industries (GTBIF) EBITDA (2019 - 2026)
Green Thumb Industries' (GTBIF) quarterly EBITDA came in at $40.7 million in Q1 2026, down 4.11% YoY from $42.5 million in Q1 2025, and up 113.89% on a QoQ basis from $19.0 million in Q4 2025.
Green Thumb Industries (GTBIF) EBITDA (2019 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 8 years of EBITDA data on file, last reported at $40.7 million in Q1 2026.
- Quarterly EBITDA fell 4.11% year-over-year to $40.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $136.0 million (down 30.72% YoY) and the FY2025 annual result came in at $137.7 million, down 38.64% from the prior year.
- EBITDA rose to $40.7 million in Q1 2026, from $19.0 million in the prior quarter.
- In the past five years, EBITDA ranged from a high of $70.7 million in Q1 2024 to a low of -$44.5 million in Q4 2022.
- A 5-year average of $41.7 million and a median of $44.2 million in 2023 frame the typical range for EBITDA.
- Annual changes were most pronounced in 2022 — EBITDA sank 181.85% — and 2023, when it surged 213.09%.
- Tracing GTBIF's EBITDA over 5 years: stood at -$44.5 million in 2022, then surged by 213.09% to $50.3 million in 2023, then gained by 13.45% to $57.1 million in 2024, then plunged by 66.65% to $19.0 million in 2025, then soared by 113.89% to $40.7 million in 2026.
- The last three EBITDA figures came in at $40.7 million (Q1 2026), $19.0 million (Q4 2025), and $36.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | -231.00 Mn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 837.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 1.26 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 330.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 6.30 Mn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 151.50 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 248.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 19.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.97 Mn |
| Mar 31, 2026 | 40.73 Mn |
| Dec 31, 2025 | 19.04 Mn |
| Sep 30, 2025 | 36.74 Mn |
| Jun 30, 2025 | 39.43 Mn |
| Mar 31, 2025 | 42.48 Mn |
| Dec 31, 2024 | 57.11 Mn |
| Sep 30, 2024 | 42.62 Mn |
| Jun 30, 2024 | 54.02 Mn |
| Mar 31, 2024 | 70.67 Mn |
| Dec 31, 2023 | 50.34 Mn |
| Sep 30, 2023 | 49.03 Mn |
| Jun 30, 2023 | 41.06 Mn |
| Mar 31, 2023 | 44.20 Mn |
| Dec 31, 2022 | -44.51 Mn |
| Sep 30, 2022 | 48.76 Mn |
| Jun 30, 2022 | 62.26 Mn |
| Mar 31, 2022 | 54.55 Mn |
| Dec 31, 2021 | 54.38 Mn |
| Sep 30, 2021 | 58.07 Mn |